A phase I trial of etanercept biosimilar (GP2015) in healthy subjects
Phase of Trial: Phase I
Latest Information Update: 16 Jun 2016
At a glance
- Drugs Etanercept (Primary)
- Indications Plaque psoriasis; Rheumatoid arthritis
- Focus Adverse reactions; Pharmacodynamics
- 16 Jun 2016 New trial record
- 09 Jun 2016 Results published in a Sandoz media release.
- 09 Jun 2016 Results presented at the Annual European Congress of Rheumatology (EULAR 2016), according to a Sandoz media release.